Literature DB >> 21684321

In vivo effect of 5-HT₇ receptor agonist on pyramidal neurons in medial frontal cortex of normal and 6-hydroxydopamine-lesioned rats: an electrophysiological study.

L L Fan1, Q J Zhang, J Liu, J Feng, Z H Gui, U Ali, L Zhang, C Hou, T Wang, Y P Hui, Y N Sun, Z H Wu.   

Abstract

The 5-hydroxytryptamine (5-HT)-7 receptor began to be cloned and pharmacologically characterized close to 20 years ago. It couples positively via G-proteins to adenylyl cyclase and activation of this receptor increases neuronal excitability, and several studies have shown that degeneration of the nigrostriatal pathway leads to an impairment of 5-HT system. Here we reported that systemic and local administration of 5-HT₇ receptor agonist AS 19 produced excitation, inhibition and no change in the firing rate of pyramidal neurons in medial prefrontal cortex (mPFC) of normal and 6-hydroxydopamine-lesioned rats. In normal rats, the mean response of the pyramidal neurons to AS 19 by systemic and local administration in mPFC was excitatory. The inhibitory effect by systemic administration of AS 19 was reversed by GABA(A) receptor antagonist picrotoxinin. Systemic administration of picrotoxinin excited all the neurons examined in normal rats, and after treatment with picrotoxinin, the local administration of AS 19 further increased the firing rate of the neurons. In the lesioned rats, systemic administration of AS 19, at the same doses, also increased the mean firing rate of the pyramidal neurons. However, cumulative dose producing excitation in the lesioned rats was higher than that of normal rats. Systemic administration of AS 19 produced inhibitory effect in the lesioned rats, which was partially reversed by picrotoxinin. The local administration of AS 19, at the same dose, did not change the firing rate of the neurons in the lesioned rats. Systemic administration of picrotoxinin and the local administration of AS 19 did not affect the firing rate of the neurons in the lesioned rats. These results indicate that activity of mPFC pyramidal neurons is regulated through activation of 5-HT₇ receptor by direct or indirect action, and degeneration of the nigrostriatal pathway leads to decreased response of these neurons to AS 19, suggesting dysfunction and/or down-regulation of 5-HT₇ receptor on the pyramidal neurons and GABA interneurons in the lesioned rats.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684321     DOI: 10.1016/j.neuroscience.2011.06.011

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Activation of 5-HT7 receptor by administration of its selective agonist, LP-211, modifies explorative-curiosity behavior in rats in two paradigms which differ in visuospatial parameters.

Authors:  Cristiana Carbone; Annalisa Adinolfi; Stefano Cinque; Enza Lacivita; Enrico Alleva; Marcello Leopoldo; Walter Adriani
Journal:  CNS Neurosci Ther       Date:  2018-02-01       Impact factor: 5.243

2.  Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia.

Authors:  Mumin Alper Erdogan; Mehmet Kirazlar; Gurkan Yigitturk; Oytun Erbas
Journal:  Neurochem Res       Date:  2022-01-21       Impact factor: 3.996

Review 3.  Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction.

Authors:  Alan L Pehrson; Connie Sanchez
Journal:  CNS Spectr       Date:  2013-08-01       Impact factor: 3.790

Review 4.  Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants.

Authors:  Alan L Pehrson; Connie Sanchez
Journal:  Drug Des Devel Ther       Date:  2015-01-19       Impact factor: 4.162

Review 5.  The 5-HT7 receptor as a potential target for treating drug and alcohol abuse.

Authors:  Sheketha R Hauser; Peter B Hedlund; Amanda J Roberts; Youssef Sari; Richard L Bell; Eric A Engleman
Journal:  Front Neurosci       Date:  2015-01-13       Impact factor: 4.677

6.  Protective Effects of 5-HT1A Receptor Inhibition and 5-HT2A Receptor Stimulation Against Streptozotocin-Induced Apoptosis in the Hippocampus.

Authors:  Siamak Shahidi; Nasrin Hashemi-Firouzi; Simin Afshar; Sara Soleimani Asl; Alireza Komaki
Journal:  Malays J Med Sci       Date:  2019-04-30

7.  Neuronal activity (c-Fos) delineating interactions of the cerebral cortex and basal ganglia.

Authors:  Mei-Hong Qiu; Michael C Chen; Zhi-Li Huang; Jun Lu
Journal:  Front Neuroanat       Date:  2014-03-26       Impact factor: 3.856

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.